Demethoxycurcumin was superior to temozolomide in the inhibition of the growth of glioblastoma stem cells in vivo
Crossref DOI link: https://doi.org/10.1007/s13277-016-5399-x
Published Online: 2016-10-18
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Leng, Liang
Zhong, Xiaojun
Sun, Guan
Qiu, Wen
Shi, Lei
Funding for this research was provided by:
National Natural Science Foundation of China (81000963, 81370062, and 81302196)
License valid from 2016-10-18